中文名 | 柴胡皂苷 A |
英文名 | saikosaponin a |
别名 | 柴胡皂苷A 柴胡皂苷a 柴胡皂苷 A 柴胡皂甙 A 柴胡皂苷A(标准品) 柴胡皂苷A(分析标准品) 柴胡皂苷 A, 来源于柴胡 SAIKOSAPONIN A 柴胡皂苷A SAIKOSAPONIN A 柴胡皂苷A 标准品 |
英文别名 | saikosaponin a SAIKOSAPONIN A sailkosaponin A Thesaikosaponin A SAIKOSAPONIN A(RG) SABINYL ACETATE(RG) dihydroxyolean-11-en-3-yl6-deoxy-3-O-β-D- β-D-fucoside, (3β,4α,16β)-13,28-epoxy-16,23- [(4R)-13,28-Epoxy-16β,23-dihydroxyolean-11-en-3β-yl]3-O-(β-D-glucopyranosyl)-6-deoxy-β-D-galactopyranoside [(3β,4R)-13,28-Epoxy-16β,23-dihydroxyolean-11-en-3-yl]3-O-(β-D-glucopyranosyl)-6-deoxy-β-D-galactopyranoside (3beta,4alpha,16beta)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl-6-deoxy-3-o-beta-d-glucopyranosyl-beta-d-galactopyranoside (3beta,13alpha,16beta,17alpha)-16,23-dihydroxy-13,28-epoxyolean-11-en-3-yl 6-deoxy-3-O-beta-D-glucopyranosyl-beta-D-galactopyranoside |
CAS | 20736-09-8 |
EINECS | 633-799-5 |
化学式 | C42H68O13 |
分子量 | 780.98 |
InChI | InChI=1/C42H68O13/c1-21-28(46)33(55-34-31(49)30(48)29(47)22(18-43)53-34)32(50)35(52-21)54-27-10-11-37(4)23(38(27,5)19-44)8-12-39(6)24(37)9-13-42-25-16-36(2,3)14-15-41(25,20-51-42)26(45)17-40(39,42)7/h9,13,21-35,43-50H,8,10-12,14-20H2,1-7H3/t21-,22-,23-,24-,25-,26+,27+,28+,29-,30+,31-,32-,33+,34+,35+,37+,38+,39-,40+,41-,42+/m1/s1 |
密度 | 1.163~1.168 g/ml |
熔点 | 225~232℃ (dec.) |
沸点 | 893.7±65.0 °C(Predicted) |
比旋光度 | (EtOH)+46 |
闪点 | 494.3°C |
蒸汽压 | 0mmHg at 25°C |
溶解度 | DMSO (微溶),甲醇 (微溶,超声处理),吡啶 (微溶) |
折射率 | 1.571~1.574 (20/D) |
酸度系数 | 12.83±0.70(Predicted) |
存储条件 | Hygroscopic, Refrigerator, under inert atmosphere |
稳定性 | 吸湿性 |
外观 | 固体 |
颜色 | White to Off-White |
物化性质 | 淡黄色结晶,易溶于水、稀醇,难溶于苯、乙醚、氯仿,来源于柴胡地上部分。 |
安全术语 | 24/25 - 避免与皮肤和眼睛接触。 |
海关编号 | 29389090 |
上游原料 | 2''-O-乙酰柴胡皂苷A |
下游产品 | 柴胡皂苷G |
参考资料 展开查看 | 1. 辛国 赵昕彤 李文 等. 不同时间煎煮柴胡对五柴胡饮中柴胡皂苷含量及药效学的影响[J]. 长春中医药大学学报 2018(4):641-644. 2. 宁艳梅 杨秀娟 陈晖 张金保 杨韬 任远.不同比例鳖血炮制柴胡制品中柴胡总皂苷含量测定与比较[J].中兽医医药杂志 2019 38(05):9-13. 3. 邱云 苏健 庞雪 等. 不同炮制方法对北柴胡中柴胡皂苷a、d的含量影响[J]. 湖南中医药大学学报 2016(2期):51-53. 4. 庞雪 廖念 周逸群 等. 不同炮制方法对北柴胡中柴胡皂苷含量的影响[J]. 时珍国医国药 2016(12):2906-2908. 5. 廖念 庞雪 周逸群 等. 北柴胡麸煨工艺的正交试验法优选[J]. 时珍国医国药 2017(05):96-98. 6. 郭泰麟 李丹丹 张慧. 南北柴胡HPLC-ELSD指纹图谱的研究[J]. 中国民族民间医药 2020 029(006):19-24. 7. 李英, 焦倩, 张天天,等. 基于地形因子的河北省北柴胡生态适宜性区划研究[J]. 中国中药杂志, 2017, 042(022):4402-4407. 8. 曹雪, 蔡广知, 赵凌,等. 基于复合质量常数的北柴胡饮片等级评价[J]. 中国实验方剂学杂志, 2018(18). 9. 胡冬蓉, 禤正正, 谢炜,等. 柴胡疏肝汤高效液相指纹图谱的建立及含量测定[J]. 时珍国医国药, 2017(6):1310-1314. 10. 朱双龙, 段会全, 刘英富,等. 柴胡皂苷a对大鼠急性脊髓损伤的神经保护作用与机制研究[J]. 中国修复重建外科杂志, 2017, 031(007):825-829. 11. 朱双龙,陈旭义,段会全,刘迎节,孙中磊,徐云强.柴胡皂苷a影响大鼠急性脊髓损伤后机体炎症水平表达的实验研究[J].天津医科大学学报,2017,23(04):300-303. 12. 潘龙,牛俊丽,卜登攀,杜洪,程建波,孙先枝,王秀敏,秦俊杰,袁耀明,张幸开.柴胡皂苷对体外发酵参数及细菌数量变化的影响[J].草业学报,2015,24(06):85-91. 13. 廖念, 庞雪, 周逸群,等. 正交试验法优选北柴胡麸炒工艺[J]. 中国药师, 2017, 020(004):738-740. 14. 赵昕彤, 辛国, 辛宇,等. 煎煮时间对柴胡中柴胡皂苷A和柴胡皂苷D含量的影响[J]. 人参研究, 2017. 15. 杨梦玲, 尤朋涛, 何丽珊,等. 基于UPLC-MS/MS分析胃溃疡模型大鼠口服加味小柴胡颗粒后血浆中8种有效成分的药代动力学[J]. 中国中药杂志, 2018, 43(18). 16. 黄湘 陈丰连 曹骋 等. HPLC-ELSD全成分指纹图谱研究疏肝理脾方配伍前后化学成分的变化[J]. 化学与生物工程 2020 037(001):59-64. 17. 李壮壮, 张静, 赵绍哲,等. 指纹图谱与化学计量学结合优选柴胡桂枝颗粒水提工艺[J]. 中成药, 2018, v.40(08):199-203. 18. Tian D-D, Wang W, Wang H-N, Sze SCW, Zhang Z-J. Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats. Molecules. 2016; 21(6):696. https://doi.org/10.3390/molecules 19. Wang, Wei, Dan-Dan Tian, and Zhang-Jin Zhang. "In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism." Molecules 21.5 (2016): 597.https://doi.org/10.3390/molecules21050597 20. [IF=4.411] Wei Wang et al."In Vitro Effects of Concomitant Use of Herbal Preparations on Cytochrome P450s Involved in Clozapine Metabolism."Molecules. 2016 May;21(5):597 21. [IF=4.411] Dan-Dan Tian et al."Pharmacokinetic Evaluation of Clozapine in Concomitant Use of Radix Rehmanniae, Fructus Schisandrae, Radix Bupleuri, or Fructus Gardeniae in Rats."Molecules. 2016 Jun;21(6):696 22. [IF=3.216] Yu Hong et al."Saikosaponin A modulates remodeling of Kv4.2-mediated A-type voltage-gated potassium currents in rat chronic temporal lobe epilepsy."Drug Des Dev Ther. 2018; 12: 2945–2958 23. [IF=3.205] Zhuangzhuang Li et al."Simultaneous quantification of fifteen compounds in rat plasma by LC-MS/MS and its application to a pharmacokinetic study of Chaihu-Guizhi decoction."J Chromatogr B. 2019 Jan;1105:15 24. [IF=5.81] Cui Lihua et al."Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway."Front Pharmacol. 2021 Jun;0:1369 25. [IF=4.534] Jikun Du et al."Saikosaponin-A induces apoptosis of cervical cancer through mitochondria- and endoplasmic reticulum stress-dependent pathway in vitro and in vivo: involvement of PI3K/AKT signaling pathway."Cell Cycle. 2021;20(21):2221-2232 26. [IF=4.36] Xiaojing Zhang et al."A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway."J Ethnopharmacol. 2022 Jan;283:114742 27. [IF=3.205] Jie Tang et al."Metabolite profiling of Shuganzhi tablets in rats and pharmacokinetics study of four bioactive compounds with liquid chromatography combined with electrospray ionization tandem mass spectrometry."J Chromatogr B. 2021 Aug;1179:122827 28. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950 29. [IF=2.977] An-rong Wang et al."Saikosaponin A improved depression-like behavior and inhibited hippocampal neuronal apoptosis after cerebral ischemia through p-CREB/BDNF pathway."Behav Brain Res. 2021 Apr;403:113138 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!